(2~{S})-2-azanyl-3-(1~{H}-1,2,3,4-tetrazol-5-yl)propanoic acid non-polymer HETAIN C4 H7 N5 O2 0 2017-05-11 2017-06-09 N REL 157.131 9DQ N Corina N 5NX2 EBI C1 C 0 1 N N N -17.481 24.101 7.447 2.519 0.125 -0.009 C57 9DQ 1 C2 C 0 1 N N S -17.221 23.713 8.912 1.077 -0.031 -0.421 C59 9DQ 2 C3 C 0 1 N N N -16.959 22.180 9.004 0.172 0.212 0.789 C60 9DQ 3 C4 C 0 1 Y N N -17.117 21.588 10.382 -1.269 0.177 0.352 C61 9DQ 4 N1 N 0 1 Y N N -16.864 22.276 11.533 -2.245 -0.598 0.861 N62 9DQ 5 N2 N 0 1 Y N N -17.086 21.502 12.593 -3.326 -0.323 0.213 N63 9DQ 6 N3 N 0 1 Y N N -17.488 20.296 12.052 -3.064 0.580 -0.666 N64 9DQ 7 N4 N 0 1 Y N N -17.500 20.371 10.666 -1.819 0.900 -0.593 N65 9DQ 8 N5 N 0 1 N N N -18.231 24.336 9.784 0.859 -1.391 -0.931 N66 9DQ 9 O1 O 0 1 N N N -16.653 24.802 6.875 3.193 -0.852 0.214 O58 9DQ 10 H2 H 0 1 N N N -16.262 24.185 9.172 0.842 0.692 -1.202 H2 9DQ 11 H3 H 0 1 N N N -17.666 21.672 8.331 0.345 -0.564 1.534 H3 9DQ 12 H4 H 0 1 N N N -15.930 21.989 8.666 0.398 1.187 1.221 H4 9DQ 13 H5 H 0 1 N N N -16.556 23.226 11.574 -2.152 -1.243 1.580 H5 9DQ 14 H6 H 0 1 N N N -18.056 24.079 10.734 1.070 -2.080 -0.225 H6 9DQ 15 H7 H 0 1 N N N -18.182 25.331 9.693 -0.084 -1.502 -1.273 H7 9DQ 16 OXT O 0 1 N Y N -18.602 23.658 6.861 3.055 1.351 0.104 OXT 9DQ 17 H1 H 0 1 N N N -18.636 23.971 5.965 3.984 1.400 0.370 H1 9DQ 18 doub N N 1 sing N N 2 sing N N 3 sing N N 4 sing N N 5 doub Y N 6 sing Y N 7 sing Y N 8 sing Y N 9 doub Y N 10 sing N N 11 sing N N 12 sing N N 13 sing N N 14 sing N N 15 sing N N 16 sing N N 17 sing N N 18 InChI=1S/C4H7N5O2/c5-2(4(10)11)1-3-6-8-9-7-3/h2H,1,5H2,(H,10,11)(H,6,7,8,9)/t2-/m0/s1 UHDMAEPGMOIEHH-REOHCLBHSA-N N[C@@H](Cc1[nH]nnn1)C(O)=O N[CH](Cc1[nH]nnn1)C(O)=O C(c1[nH]nnn1)[C@@H](C(=O)O)N C(c1[nH]nnn1)C(C(=O)O)N (2~{S})-2-azanyl-3-(1~{H}-1,2,3,4-tetrazol-5-yl)propanoic acid EBI RCSB